Mathai Mammen - EVP, Pharm, R&D at Johnson & Johnson

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Pharm, R&D
Stock Symbol
JNJ on NYSE
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mathai Mammen since 7/14/2023

Holdings reported by Mathai Mammen for Johnson & Johnson

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 41.9 K $7.21 M $172.00 Feb 15, 2022 Direct
Employee Stock Options (Right to Buy) 38.7 K $2.81 M $72.54 Feb 14, 2022 Direct Common Stock
Restricted Share Units 3.92 K $613 K $156.33 Feb 14, 2022 Direct Common Stock
Performance Share Units 737 $116 K $157.40 Feb 15, 2022 Direct Common Stock

Transactions reported by Mathai Mammen for Johnson & Johnson

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership